WaferGen Bio Buy Hold or Sell Recommendation

WGBS -- USA Stock  

USD 6.90  0.00  0.00%

Given the investment horizon of 30 days, and your above average risk tolerance our recommendation regarding WaferGen Bio systems is 'Not Rated'. Macroaxis provides WaferGen Bio buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding WGBS positions. The advice algorithm takes into account all of WaferGen Bio systems available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from WGBS buy-and-hold prospective. See also Your Current Watchlist.

Time Horizon

Risk Tolerance

Symbol
Execute Advice
Sell WaferGen BioBuy WaferGen Bio
Not Rated
For the selected time horizon WaferGen Bio systems has a risk adjusted performance of 0.0, jensen alpha of 0.0, total risk alpha of 0.0, sortino ratio of 0.0 and treynor ratio of 0.0
We provide recommendation to complement the prevalent expert consensus on WaferGen Bio systems. Our dynamic recommendation engine utilizes multi - dimensional algorithm to analyze the firm potential to grow using all technical and fundamental data available at the time. To make sure WaferGen Bio systems is not overpriced, please check out all WaferGen Bio systems fundamentals including its Price to Book, Cash Flow from Operations, Z Score, as well as the relationship between Cash and Equivalents and Total Asset . Given that WaferGen Bio systems has Number of Shares Shorted of 240.41 K, we strongly advise you confirm WaferGen Bio systems market performance and probability of bankruptcy to make sure the company can sustain itself in the current economic cycle given your prevalent risk tolerance and investing horizon.

Institutional Investors

Security TypeSharesValue
Sabby Management LlcCommon Shares358.5 K1.8 M
Opaleye Management IncCommon Shares320 K1.6 M
Vanguard Group IncCommon Shares21.1 K104 K
Creative PlanningCommon Shares20.9 K103 K
Ubs Group AgCommon Shares6.3 K31 K
Blackrock Fund AdvisorsCommon Shares1.4 K7 K
Deutsche Bank AgCommon Shares1.00.0
   WaferGen Bio exotic insider transaction detected [view details]

WaferGen Bio Alerts

Trading Alerts and Improvement Suggestions
WaferGen Bio systems generates negative expected return over the last 30 days
WaferGen Bio systems has high likelihood to experience some financial distress in the next 2 years
The company reported previous year revenue of 9.24 M. Net Loss for the year was (20.85 M) with profit before overhead, payroll, taxes, and interest of 3.95 M.
WAFERGEN BIO-SYST currently holds about 5.15 M in cash with (13.54 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.36.
Roughly 20.0% of the company outstanding shares are owned by insiders
See also Your Current Watchlist. Please also try Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.